Objective: The aim of this study was to analyze coronary artery vitamin D receptor (VDR) expression, the plasma concentrations of 25-hydroxyvitamin D 3 (25OHD 3 ), and their relationship with coronary artery atherosclerosis.
T he biologically active form of vitamin D (1,25dihydroxyvitamin D 3 [1, 25 (OH) 2 D 3 ]) is a fat-soluble vitamin. 1 It is the only vitamin that can be acquired via endogenous production from 7-dehydrocholesterol after exposure to ultraviolet B light. 2<4 The measurement of 1,25(OH) 2 D 3 can be misleading with respect to whole body stores of 25-hydroxyvitamin D (25OHD) because of compen-satory mechanisms (ie, secondary hyperparathyroidism) that may mask low 25OHD concentrations. 3<6 Consequently, the isomer 25OHD (both 25OHD 2 and 25OHD 3 ) is traditionally measured in plasma to determine the adequacy of vitamin D stores rather than the active form.
Although the role of vitamin D and skeletal health is well understood, 7 more recent evidence has suggested potential nonskeletal benefits to vitamin D. These benefits may include the prevention of various cancers, 8 psoriasis, 9 multiple sclerosis, 10 and coronary heart disease (CHD). 11, 12 There are many well-established pathophysiological reasons to indicate that vitamin D may have a beneficial role in cardiovascular health. These include vitamin D's ability to inhibit vascular smooth muscle cell proliferation, vascular calcification, and atherogenesis via anti-inflammatory pathways (including effects on C-reactive protein, cytokines, tumor necrosis factor, interleukin-6, and matrix metallopro-teinaseY9). 13<17 Vitamin D has been shown to improve insulin sensitivity 18, 19 and to have a beneficial association with diabetes mellitus. 20<24 Vitamin D has been associated with enhanced vascular reactivity 25 and can control hypertension through its effect on intravascular volume via the reninangiotensin-aldosterone system. 26, 27 Vitamin D deficiency also has been associated with heart failure 28, 29 and a worsening thrombogenic profile. 30 Despite these mechanisms explaining a logical link between vitamin D and CHD, there are no good prospective studies to support this concept. In accordance, the recent Institute of Medicine report emphasized the need to explore further evidence and/or knowledge about the potential association between vitamin D and CHD. 7 Although most physicians, as well as researchers, are focusing on vitamin D 3 supplementation, an adequate/optimal dose and the target plasma concentration are not well defined. There are still many simple unanswered questions. For example, although a strong genetic link for the plasma concentration and physiologic variability of vitamin D has been suggested, 31<33 it has not been well defined what parameters are under genetic influence. In addition, it is not known whether there are genetic variations in vitamin D metabolism, intestinal absorption, production of transport proteins, vitamin D receptor (VDR) concentrations, or activity levels. Clinically, it is evident that responses to standard doses of vitamin D 3 supplementation are variable. The results of such studies have suggested that 18% to 53% of individuals will not respond to vitamin D supplementation despite oral doses of between 2,000 and 8,000 IU per day of vitamin D 3 . 34, 35 Similarly, we have shown previously that plasma concentrations of 25OHD 3 varied considerably (26 to 95 ng/mL) in monkeys consuming diets with identical amounts of vitamin D 3 and where living conditions along with sun exposure were the same. 36 The clinical implications and meaning of such a wide range of plasma concentrations are not known. Recent data from investigations using mice suggest that vitamin DYbinding protein (DBP) can influence the plasma concentration of 1,25(OH) 2 D 3 without affecting biologic activity. 37 Mice deficient in DBP had significantly reduced plasma concentrations of 1,25(OH) 2 D 3 , yet their serum calcium (a marker of vitamin D activity) was normal and not significantly different from that of the control mice. 37 Studies also suggest that DBP is involved in the delivery of vitamin D to the nuclear site of vitamin D activation, the VDR. 37, 38 VDRs have been localized and identified in many tissues including the pancreas, 39 lung, 40 myocardium, 41 skeletal muscle, 42 brain, 43 bone, 44 and ovary. 45 The potential importance of coronary VDR in the pathogenesis of coronary artery atherosclerosis has not been studied previously, nor has the possible interaction between coronary artery VDR expression, plasma concentrations of 25OHD, and coronary artery atherosclerosis. For these reasons, we quantified the expression of VDR in coronary arteries of cynomolgus monkeys, measured their plasma concentrations of 25OHD 3 , and correlated those results with the degree of coronary artery atherosclerosis.
METHODS

Animals and diets
After arriving at the Wake Forest University Primate Center from Indonesia, our cohort of 39 female cynomolgus monkeys (Macaca fascicularis) were housed indoors with no ultraviolet exposure for 3 months before the beginning of the study. Beginning at arrival, they were fed a diet that contained a woman's equivalent of 1,000 IU/day of vitamin D 3 and 1,200 mg/day of calcium. Furthermore, and throughout the study, they were fed atherogenic diets with a woman's equivalent of 1,000 IU/day of vitamin D 3 and 1,200 mg/day of calcium.
All animals were housed indoors during the entire length of the study. Dentition and evidence of physeal closure were used to determine adult status in the monkeys that, on average, was 11.5 years. After 32 months of consuming diet A (casein-lactalbumin [C/L] or soy protein isolate [soy]), each monkey underwent oophorectomy to induce surgical menopause. Each diet group was then rerandomized to receive diet B (C/L or soy). A total of 10 received C/L-soy, 10 received C/L-C/L, 9 received soy-C/L, and 10 received soy-soy, enhancing the likelihood of a broad range of coronary artery atherosclerosis. After 32 postmenopausal months and necropsy, coronary artery atherosclerosis, coronary artery VDR expression, and 25OHD 3 concentrations were assessed. Both the C/L and soy diets contained 19% calories from protein, 35% calories from fat, 46% calories from carbohydrate, and 0.20 mg cholesterol/cal. Both diets used wheat flour as a source for protein. The soy diet contained 1.85 mg aglycone isoflavones/g protein (SUPRO SOY Isolated Soy Protein; Solae, St. Louis, MO).
All procedures involving animals in this study were conducted in compliance with state and federal laws, standards of the US Department of Health and Human Services, and guidelines established by the Wake Forest University Institutional Animal Care and Use Committee, where the animals were housed. Wake Forest University is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. An adiposity index for the monkeys was derived by measuring body weight by trunk length, and has a normal range of 35 to 55 kg/m 2 . Trunk length is measured from the sternal notch to the public symphysis. such that they were protected from sunlight, transported to The Reading Hospital and Medical Center, Reading, PA, 36, 46 and had never been thawed before the 25OHD 3 assessments. High-performance liquid chromatography/tandem mass spectrometry using Shimadzu liquid chromatographyYmass spectrometry/mass spectrometry (LC-MS/2) technology was used for determination of 25OHD 3 . Liquid chromatographyYmass spectrometry allows the sample to be ionized, through the physical separation abilities of liquid chromatography, for mass analysis using the AB Sciex 3200 Q Trap mass spectrometer.
Atherosclerosis evaluation
The cross-sectional area of atherosclerotic plaques (intimal area [IA] in square millimeters) and maximal plaque thickness (in millimeters), or maximal intimal thickness (IT), were determined for the left circumflex (LCX) artery and the left anterior descending (LAD) artery from the proximal portions of those arteries obtained at necropsy. The sections of each artery, 0.5 cm in length, were placed into 70% ethanol, dehydrated, and embedded into paraffin blocks. Blocks were cut to 5-Km sections, which were then deparaffinized and stained using the Verhoeff and Van Gieson stain. Plaque size (IA) and plaque thickness (IT) were assessed using computer-assisted histomorphometry using Image Pro Plus software (Media Cybernetics Inc., Silver Springs, MD). Measurements were conducted by an experienced technician using a well-established protocol. 47 Identification of the VDR and quantification using the H-score method
For the quantification of VDR, to eliminate the potential of intraobserver or interobserver variation and interpretation bias, one consistent and blinded observer was used for all measurements. To assure validity and reproducibility, however, the following steps were taken before quantification, and observations were carried out. The designated observer met with other trained observers to co-analyze specimens assuring consistent and reproducible results.
The quantity of coronary artery VDRs was subsequently determined for the LAD by determining the intimal H-score. Artery blocks were cut to 5-Km sections, which were deparaffinized and immunohistochemically stained for the VDR. The sections were treated using rat antiYvitamin D receptor monoclonal antibody (Thermo Scientific, Rockford, IL) and then treated using biotinylated goat antirat (Serotec, Raleigh, NC), with the enzyme conjugate steptavidin-alkaline phosphatase (BioGenex, San Ramon, CA) and enzyme substrate vector red (Vector Laboratories, Burlingame, CA). For counting, only a hematoxylin counterstain was used; the internal elastic lamina was visible as a refractile line. For demonstration of the internal elastic lamina for photomicroscopy ( Fig. 2) , slides were further stained for elastin using a modified Weigert resourcin-fuchsin method, 48 hematoxylin, and metanyl yellow.
All cells in all layers of the section were counted, including the endothelium, intima, media, and adventitia. For this study, the adventitia was defined as tissue within 250 microns of the outermost edge of the media. Cells were counted using a light microscope at Â400 magnification and a key counter. H-score was calculated using a method described by Siboni et al. 49 All cells were assigned a grade of 0, 1, 2, or 3, where a grade 0 indicated a nucleus with no red stain, a grade 1 indicated a slightly red stained nucleus, a grade 2 indicated a moderately stained red nucleus, and a grade 3 indicated a dark and diffusely stained red nucleus. The intimal H-score was determined from calculating 3 times the percentage of grade 3 cells plus 2 times the percentage of grade 2 cells plus 1 times the percentage of grade 1 cells plus 0 times the percentage of grade 0 cells in the intima. This summative score, with a possible minimum of 0 and a possible maximum of 300, will be referred to as the intimal H-score.
Statistical analyses
Descriptive statistics comprised means and SDs for continuous data (eg, age, adiposity index). Data were evaluated for normality and had a Gaussian distribution. Analysis of variance (ANOVA) was used to compare cross-sectional area of plaques as a function of high VDR, low VDR, and 25OHD 3 , whereas a post hoc Scheffé test was used to compare between-group differences. Correlations were analyzed using Pearson correlation coefficients.
SPSS version 17.0 (SPSS Inc., Chicago, IL) was used for all analyses. An a priori > level of 0.05 was used such that all results yielding P G 0.05 were deemed statistically significant.
RESULTS
A total of 39 female cynomolgus monkeys all received moderately atherogenic diets with a woman's equivalent of 1,000 IU/day of vitamin D 3 and 1,200 mg/day of calcium throughout the study. At necropsy, the mean T SD age (range) was 21.6 T 3.0 (14.2-26.3) years; the mean weight was 3.6 T 0.9 kg (1.9-5.4 kg), and the mean adiposity index was 49.8 T 11.3 kg/m 2 (28.8-70.5 kg/m 2 ).
We analyzed the relationships between the plasma concentration of 25OHD 3 and the expression of VDR in the LAD artery and there was no correlation (Fig. 1) . In addition to those measurements, coronary artery atherosclerosis was analyzed in all monkeys using both the cross-sectional area (in square millimeters) and plaque thickness (in millimeters) in the LCX as well as the LAD arteries (Fig. 2) .
When monkeys with higher (above the median) plasma 25OHD 3 concentrations and higher VDRs were compared with those with higher plasma 25OHD 3 concentrations and lower VDR, we noted that the monkeys with smaller plaque sizes in both the LAD and LCX arteries (Fig. 3 ) had higher plasma 25OHD 3 concentrations and higher VDRs (P = 0.016). For the LCX artery, there was also a significantly lower plaque size for both plaque thickness and cross-sectional area (Fig. 3) in those with higher VDR and lower plasma 25OHD 3 concentrations versus those with lower quantities of VDR and higher plasma concentrations of 25OHD 3 (P = 0.040 and P = 0.009, respectively).
DISCUSSION
Vitamin D is a fat-soluble vitamin that is bound to a carrier protein (DBP), which has been thought to safely transport hydrophobic vitamin D through the plasma environment to the VDR. VDRs are localized to specific regions of target genes where 1,25(OH) 2 D 3 (converted from 25OHD 3 ) is subsequently able to modify their transcriptional abilities. 37,50<52 Although VDRs have been localized in many diffuse body organs, 39<44 little is known about the expression of VDR and its association with disease in those organs. VDR null mice have been shown to have greater systemic inflammation 53 and are more susceptible to autoimmune diseases as well as oncogenic-and chemocarcinogenic-induced tumors. 54 It is not known, however, if this is related to a lack of 25OHD 3 effect (ie, 25OHD 3 deficiency) or a lack of VDR, or, more importantly, what role a low expression of VDRs would have over time. Therefore, it can be viewed as a novel finding that a high VDR expression was associated with a significantly lower degree of coronary artery atherosclerosis compared with a low VDR expression and a high plasma concentration of 25OHD 3 (but not a low concentration of 25OHD 3 ; Fig. 3 ).
The meaning of this finding, however, is less clear. The fact that there is no direct correlation between plasma 25OHD 3 concentration and VDR expression ( Fig. 1) , along with our analysis of VDR and coronary atherosclerosis alone, 55 suggests the greater association is between VDR expression and coronary artery atherosclerosis. The results also indicate that plasma concentrations of vitamin D play a role. One potential explanation is an in vivo stimulation of enhanced 25OHD 3 production, or absorption, in response to the greater coronary artery atherosclerosis, alone or in combination with low VDR quantity. There is also evidence that although low plasma concentrations of 25OHD could be associated with cardiovascular compromise, there may also be an upper limit, above which detriment is again seen. 11 This could be thought of as a therapeutic window, where low and high levels of plasma 25OHD were detrimental. This could also provide another potential reason for seeing a significantly worse coronary artery atherosclerosis result in those with low VDR expression (presumably detrimental), along with a high plasma 25OHD concentration (ie, this may represent individuals above the therapeutic window).
Although these data are clearly intriguing and innovative, it will be important to further elucidate what this association among VDR expression, plasma concentration of 25OHD 3 , and coronary artery atherosclerosis means. Because our data looked at one fixed point in time (necropsy), we are unable to determine whether a lower VDR expression and/or higher plasma concentrations precede coronary artery atherosclerosis or vice versa. This knowledge would be tremendously valuable. The former, for instance, would suggest that the plasma concentration and VDR expression could be predictive, and potentially modifiable, factors in the development of coronary artery atherosclerosis. On the contrary, the latter finding could simply mean that after the development of coronary artery atherosclerosis, the body responds with changes in the expression of VDR locally and, perhaps, systemic plasma 25OHD 3 concentrations.
The ideal study would begin with women on a subtherapeutic vitamin D 3 dose (to prevent rickets) while measuring baseline arterial (eg, iliac artery) VDR expression. Female participants would then be randomized to higher versus lower supplemental doses of vitamin D 3 , with the primary endpoint being the degree of atherosclerosis progression, both in the contralateral iliac artery and coronary arteries.
Limitations of the current study include the relatively small sample size; hence, some of the apparent differences may not be significant because of a type II error. In addition, because our data are all from one time point (necropsy), we are unable to determine a timeline and, hence, the potential predictive relationship among VDR expression, 25OHD 3 plasma concentrations, and coronary artery atherosclerosis.
The strengths of the study include the novel approach to detecting VDR expression and correlating this with plasma 25OHD 3 concentrations in association with coronary artery atherosclerosis. An additional strength is the fact that we were able to tightly control the diet, vitamin D 3 dose, compliance, and housing/sun exposure. Finally, the ability to correlate the 25OHD 3 and VDR data with histologic coronary artery tissue specimens is a major strength.
CONCLUSIONS
Cynomolgus monkeys with higher quantities of VDR have significantly less atherosclerosis than do those with lower quantities of VDR and higher plasma 25OHD 3 concentrations. The reason that there is an increased plasma 25OHD 3 concentration with a decrease in VDR in association with FIG. 3 . The cross-sectional area of the LCX artery according to the left anterior descending coronary artery VDR quantity and plasma 25OHD 3 concentration for the 39 female cynomolgus monkeys in this study. The higher (j) categories indicate values greater than or equal to the median, whereas the lower (,) categories indicate values less than the median. The symbols j or ,/j or , (Qmedian or Gmedian, respectively) represent VDR expression and plasma 25OHD 3 concentration, respectively. VDR, vitamin D receptor; D 3 , 25OHD 3 ; LCX, left circumflex. coronary artery atherosclerosis, and which came first, is not known. If these findings translate to human beings, it might explain why some individuals with higher plasma concentrations of 25OHD 3 have more coronary artery atherosclerosis. The extent to which VDR may be an essential component related to 25OHD 3 concentrations and the role this plays in competitive feedback is not established and should be a focus of future research. Although VDR expressions in the coronary arteries have no direct association with plasma concentrations of 25OHD 3 , there is a significant association between plasma concentration of 25OHD 3 , VDR expression, and coronary artery atherosclerosis. Further elucidation of this association and prospective trials would be intriguing and important.
